ARCHIVES

ASCO Briefing Highlights Seven Studies That Could Change Clinical Practice

This article is from The Cancer Letter archive.

Vol. 32 No. 5 | May 29, 2009

Download PDF Visit The Full Archive

Related Articles

Griesmer To Leave NTP, Will Return To Oak Ridge

March 28, 1980

Tivozanib Trumps Sorafenib In 1st-Line Renal Cancer Study

May 25, 2012

In Brief: NCAB to Hear Program Review, Reports On AIDs Monoclonal Antibodies, Cancer Research at Drew

November 25, 1983

Moses, Wattenberg Lead AACR; NCI Budget Cut By $4.8 Mil. For Shannon Awards Contribution

May 24, 1991

HHS News: Shalala Appoints Group On Genetic Testing

June 25, 1999

ODAC Recommends Fludarabine Approval for Refractory CLL

September 21, 1990